On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like…
Continue ReadingTag: GLP1
GLP-1 RAs Increase Residual Gastric Content But Pose Low Medical Risk During Endoscopy
Use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) is associated with significantly increased rates of residual gastric…
Continue Reading